Despite A Wide Retreat From Discovery Research By Multinationals In Japan, Some Are Staying Put (Part 2 Of 3)

Several multinational pharmaceutical companies have shut down their Japan-based discovery research facilities over the last few years. Some are relying more on discovery partnerships with local drug research entities in Japan. PharmAsia News' Tokyo bureau examines the factors behind the trend in this second article in a three-part series on the subject. Part one appeared in PharmAsia News on July 13, 2009.